Your browser doesn't support javascript.
loading
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma.
Shabsigh, Ahmad; Kleinmann, Nir; Smith, Angela B; Scherr, Douglas; Seltzer, Elyse; Schoenberg, Mark; Lerner, Seth P.
Affiliation
  • Shabsigh A; Department of Urology, The Ohio State University Comprehensive Cancer Center, 300 W 10th Ave, Columbus, OH, 43210, USA. Ahmad.Shabsigh@osumc.edu.
  • Kleinmann N; Department of Urology, Sheba Medical Center, Ramat Gan, Israel.
  • Smith AB; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Scherr D; Department of Urology, Weill Medical College of Cornell University, New York, NY, USA.
  • Seltzer E; UroGen Pharma, New York, NY, USA.
  • Schoenberg M; UroGen Pharma, New York, NY, USA.
  • Lerner SP; Department of Urology, Albert Einstein College of Medicine, Bronx, NY, USA.
Cancer Chemother Pharmacol ; 87(6): 799-805, 2021 06.
Article in En | MEDLINE | ID: mdl-33677615

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Tract / Urologic Neoplasms / Mitomycin / Gels Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2021 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Tract / Urologic Neoplasms / Mitomycin / Gels Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2021 Type: Article Affiliation country: United States